Telfast BD 60mg (10 tablets/box)

Indications

The symptomatic relief of seasonal allergic rhinitis, chronic idiopathic urticarial in adults and children older than 6 years of age.

Contraindications

Known hypersensitivity to any ingredient in the formulation.

Compositon/Ingredients

Dosage and administration

Adults and children aged 12 years and over: 60 mg twice daily or 180 mg once daily. Children 6 – 12 years of age: 30 mg twice daily. Patients with impaired renal function or those on hemodialysis: Adults and children aged 12 years and over: 60 mg once daily.

Precaution

Monitoring renal function may be useful and dosage should be selected with caution in elderly patients. Fexofenadine has been associated with increased QTc interval, syncope, and ventricular arrhythmia in at least one susceptible patient with preexisting cardiovascular risk. Patients also should be advised not to use other antihistamines or decongestants for self-medication. If nervousness, dizziness, or sleepiness occurs during therapy, patients should be advised to discontinue use of the fixed-combination preparation and consult a clinician. Telfast BD 60mg should be used during pregnancy only when the potential benefits justify the possible risks to the fetus. Fexofenadine should be used with caution in nursing women, and a decision should be made whether to discontinue nursing or the drug. Patients should be aware of how they react to Telfast BD 60mg before driving or operating machinery.

Storage

Store at temperature below 30°C, protect from light.